Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1233 | 1156 | 1375 | 902 | 1554 | - |
Fund Return | 23.28% | 15.59% | 37.53% | -3.39% | 9.21% | - |
Place in category | 241 | 42 | 210 | 465 | 311 | - |
% in Category | 43 | 9 | 38 | 87 | 67 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Wasatch Core Growth Institutional | 2.7B | 24.05 | 5.76 | 13.38 | ||
Wasatch Core Growth | 2.12B | 23.93 | 5.63 | 13.24 | ||
Wasatch Small Cap Value Fund Instit | 1.01B | 22.49 | 9.47 | 11.32 | ||
Wasatch Small Cap Growth Investor | 905.34M | 23.18 | -3.48 | 10.82 | ||
Wasatch Ultra Growth | 627.21M | 19.25 | -4.98 | 13.63 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Explorer Adm | 20.44B | 18.93 | 3.83 | 11.18 | ||
Vanguard Small Cap Growth Index Adm | 15.8B | 25.15 | 3.40 | 9.95 | ||
Neuberger Berman Genesis R6 | 4.72B | 20.81 | 5.85 | 10.95 | ||
T. Rowe Price QM US Small-Cap Gr Eq | 4.55B | 23.86 | 6.68 | - | ||
T. Rowe Price Instl Small-Cap Stock | 4.55B | 20.24 | 3.51 | 10.88 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Clearwater Analytics Holdings Inc Class A | - | 4.03 | - | - | |
Healthequity Inc | US42226A1079 | 3.88 | 95.09 | +0.15% | |
RBC Bearings | US75524B1044 | 3.74 | 304.62 | -0.54% | |
Bellring | US07831C1036 | 3.70 | 76.14 | +0.05% | |
The Ensign | US29358P1012 | 3.54 | 133.85 | -0.55% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review